C5-pyrimidine-functionalized morpholino oligonucleotides exhibit differential binding affinity, target specificity...

Area of Science:

• Medicinal Chemistry
• Oligonucleotide Therapeutics
• Biotechnology

Background:

• Phosphorodiamidate Morpholino Oligonucleotides (PMOs) are key in antisense technology.
• Enhancing PMO binding affinity and stability is crucial for therapeutic development.

Purpose of the Study:

• To synthesize and evaluate C5-substituted uridine and cytidine morpholino chlorophosphoramidate monomers.
• To assess the impact of these substitutions on PMO properties, including RNA binding and stability.

Main Methods:

• Semi-automated solid-phase synthesis of a 12-mer PMO.
• Incorporation of C5-substituted pyrimidine monomers.
• Thermal stability assays (Tm), RNA/DNA binding studies, Circular Dichroism (CD) spectroscopy, and High-Performance Liquid Chromatography (HPLC).

Main Results:

• Most C5-substituted PMOs exhibited significantly increased thermal stability when hybridized to RNA.
• Enhanced binding affinity was observed with RNA compared to DNA.
• CD spectra confirmed a B-type helical conformation for the PMO-RNA duplexes.
• HPLC analysis revealed increased lipophilicity of the modified PMOs.

Conclusions:

• Pyrimidine C5-substitutions represent a promising strategy for improving PMO characteristics.
• These modifications enhance RNA binding and thermal stability, advancing antisense technology development.
• Increased lipophilicity may facilitate cellular uptake and delivery of PMO-based therapeutics.